Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 7:03 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $15.29 | $229,386 | 1,333,214 (Indirect Direct) | View |
| 2023-01-04 Sale | 2024-01-05 7:18 pm | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 106,373 | $15.7 | $1,670,460 | 495,581 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 5:05 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $15.67 | $235,088 | 1,349,957 (Indirect Direct) | View |
| 2023-12-20 Sale | 2023-12-22 6:27 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 152,205 | $15.44 | $2,350,789 | 1,606,892 (Indirect Direct) | View |
| 2023-12-20 Sale | 2023-12-22 6:26 pm | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 15,183 | $15.46 | $234,720 | 38,037 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 6:25 pm | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 11,884 | $15.46 | $183,692 | 223,980 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 6:24 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 7,934 | $15.46 | $122,637 | 130,694 (Direct) | View |
| 2023-12-13 Sale | 2023-12-15 7:35 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 8,759 | $16.01 | $140,190 | 131,200 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 8:32 pm | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 3,323 | $8.8615 | $29,447 | 235,864 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 8:30 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 11,788 | $8.8615 | $104,459 | 1,033,570 (Indirect Direct) | View |
| 2023-07-31 Sale | 2023-08-01 8:28 pm | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 3,066 | $8.8615 | $27,169 | 45,620 (Direct) | View |
| 2023-07-31 Sale | 2023-08-01 8:24 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 1,888 | $8.8615 | $16,731 | 139,959 (Direct) | View |
| 2023-07-03 Sale | 2023-07-03 7:43 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $8.8495 | $144,743 | 321,467 (Indirect Direct) | View |
| 2023-05-23 Sale | 2023-05-25 7:39 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 10,000 | $10 | $100,000 | 141,847 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 7:12 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $6.0856 | $124,407 | 337,823 (Indirect Direct) | View |
| 2023-03-06 Sale | 2023-03-08 5:45 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 5,000 | $7.7474 | $38,737 | 151,847 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Equity Swap | 2024-02-20 8:07 pm | N/A N/A | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,969,108 | $0 | 0 (Indirect) | View |
| 2024-02-19 Disposition | 2024-02-20 8:07 pm | N/A N/A | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 39,278 | $0 | 0 (Indirect) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:58 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. See Remarks | 1,012,733 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:58 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. See Remarks | 2,819,007 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:52 pm | N/A N/A | Icosavax Inc. | ICVX | Khan Amin See Remarks | 300,000 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:51 pm | N/A N/A | Icosavax Inc. | ICVX | Veneman Ann M See Remarks | 11,209 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:51 pm | N/A N/A | Icosavax Inc. | ICVX | Veneman Ann M See Remarks | 67,612 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:50 pm | N/A N/A | Icosavax Inc. | ICVX | Cearley Cassia See Remarks | 131,799 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:50 pm | N/A N/A | Icosavax Inc. | ICVX | Cearley Cassia See Remarks | 699,839 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:48 pm | N/A N/A | Icosavax Inc. | ICVX | FIELDS HEIDI See Remarks | 11,376 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:48 pm | N/A N/A | Icosavax Inc. | ICVX | FIELDS HEIDI See Remarks | 67,461 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:44 pm | N/A N/A | Icosavax Inc. | ICVX | Wassil Jim See Remarks | 3,695 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:44 pm | N/A N/A | Icosavax Inc. | ICVX | Wassil Jim See Remarks | 68,948 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:43 pm | N/A N/A | Icosavax Inc. | ICVX | Russo Thomas Joseph See Remarks | 39,367 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:43 pm | N/A N/A | Icosavax Inc. | ICVX | Russo Thomas Joseph See Remarks | 773,590 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:41 pm | N/A N/A | Icosavax Inc. | ICVX | Shiver John W. See Remarks | 8,066 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:41 pm | N/A N/A | Icosavax Inc. | ICVX | Shiver John W. See Remarks | 54,976 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:38 pm | N/A N/A | Icosavax Inc. | ICVX | MCDADE MARK See Remarks | 3,566,014 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:38 pm | N/A N/A | Icosavax Inc. | ICVX | MCDADE MARK See Remarks | 39,278 | $0 | 0 (Direct) | View |
| 2024-02-19 Equity Swap | 2024-02-20 7:31 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan See Remarks | 223,980 | $0 | 0 (Direct) | View |
| 2024-02-19 Disposition | 2024-02-20 7:31 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan See Remarks | 546,131 | $0 | 0 (Direct) | View |
| 2024-02-01 Gift | 2024-02-02 7:03 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 6,532 | $0 | 1,333,214 (Indirect) | View |
| 2024-02-01 Exercise | 2024-02-02 7:03 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $0 | 1,333,214 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-02 7:03 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $1.04 | 1,333,214 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-23 6:15 pm | N/A 2030-05-10 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 98,016 | $0 | 1,354,746 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-23 6:15 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 4,789 | $0.84 | 1,354,746 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-23 6:15 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 93,227 | $1.04 | 1,354,746 (Direct) | View |
| 2023-01-04 Exercise | 2024-01-05 7:18 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 11,947 | $5.9 | 495,581 (Direct) | View |
| 2023-01-04 Exercise | 2024-01-05 7:18 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 5,972 | $15 | 495,581 (Direct) | View |
| 2023-01-04 Exercise | 2024-01-05 7:18 pm | N/A 2030-08-06 | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 106,373 | $0 | 495,581 (Direct) | View |
| 2023-01-04 Exercise | 2024-01-05 7:18 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 13,806 | $0.84 | 495,581 (Direct) | View |
| 2023-01-04 Exercise | 2024-01-05 7:18 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 74,648 | $1.04 | 495,581 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 5:05 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $0 | 1,349,957 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 5:05 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 15,000 | $1.04 | 1,349,957 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:27 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 40,000 | $2.47 | 1,606,892 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:27 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 165,917 | $0 | 1,606,892 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:27 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 102,574 | $1.04 | 1,606,892 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:27 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 23,343 | $0.84 | 1,606,892 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-01 8:54 pm | N/A 2030-05-10 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 3,000 | $0 | 1,064,702 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-01 8:54 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 3,000 | $0.84 | 1,064,702 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-03 7:43 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $0 | 321,467 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-03 7:43 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $1.04 | 321,467 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:48 pm | N/A 2033-06-11 | Icosavax Inc. | ICVX | Khan Amin EVP, Head of Research & Dev. | 180,000 | $0 | 180,000 (Direct) | View |
Ownership | 2023-06-14 7:40 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Khan Amin EVP, Head of Research & Dev. | 0 | $0 | 120,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 8:46 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | MCDADE MARK Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:47 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 17,000 | $0 | 17,000 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 4:45 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | Wassil Jim Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:44 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | Veneman Ann M Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:42 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | Shiver John W. Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:41 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | FIELDS HEIDI Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $0 | 337,823 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $1.04 | 337,823 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 7:16 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 7:13 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 7:10 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |